Table 2. Lesion characteristics and diagnostic yield and final histological diagnosis displayed according to pancreatic and extra-pancreatic site.
| Lesion site | n (%) | Diagnostic yield, n (%) | Final diagnosis |
| Pancreatic | 170 (45 %) | 156 (92 %) | 134 DACs 18 NETs 10 chronic pancreatitis 3 metastases 2 pseudopapillary tumor Other (n = 3) 1 |
| Uncinate | 16 (4 %) | ||
| Head | 107 (29 %) | ||
| Body | 38 (10 %) | ||
| Tail | 9 (2 %) | ||
| Extra-pancreatic | 208 (55 %) | 183 (88 %) | 89 adenocarcinomas 29 GISTs 26 lymphomas 12 benign lymphocytes 7 sarcoidosis 5 leiomyomas 4 each for germ cell tumor, SCC, and benign gastric cells 3 NETs 3 reactive lymph nodes 3 Leiomyosarcomas Other (n = 19) 2 |
| Esophagus | 5 (1 %) | ||
| Stomach | 53 (15 %) | ||
| Duodenum | 11 (3 %) | ||
| Abdominal lymph nodes | 61 (16 %) | ||
| Mediastinum | 43 (11 %) | ||
| CBD or gallbladder | 12 (3 %) | ||
| Rectal or peri-rectal | 16 (4 %) | ||
| Liver | 5 (1 %) | ||
| Other 3 | 2 (1 %) |
DAC, ductal adenocarcinoma; FN, false negative; IPMN, intraductal papillary mucinous neoplasm; NET, neuroendocrine tumor; SCC, squamous cell cancer; SMT, submucosal tumor.
1
n = 1 each for IPMN, mucinous cystoadenocarcinoma, and accessory spleen.
2
Small cell lung cancer, tuberculosis, Schwannoma, renal cell cancer (n = 2 for each); benign biliary cells, HCC, endometrial cancer, uterine cervical cancer, mesothelioma, ovarian cancer, melanoma, pancreatic rest, paraganglioma, glomic tumor, haemangioma.
3
n = 1 each for left adrenal gland and spleen.